| Code | Description | Claims | Beneficiaries | Total Paid |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
746 |
699 |
$146K |
| 87184 |
|
2,155 |
1,752 |
$97K |
| 87070 |
|
7,512 |
7,119 |
$70K |
| 87077 |
|
7,794 |
7,130 |
$67K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,180 |
1,041 |
$23K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
898 |
790 |
$22K |
| 87075 |
|
1,678 |
1,599 |
$14K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
253 |
222 |
$13K |
| 87147 |
|
1,437 |
1,353 |
$8K |
| 87205 |
|
1,033 |
978 |
$5K |
| 87071 |
|
696 |
666 |
$4K |
| 87073 |
|
660 |
628 |
$4K |
| 87088 |
|
209 |
174 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
231 |
211 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
40 |
39 |
$2K |
| 87185 |
|
256 |
248 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
38 |
37 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
39 |
38 |
$990.70 |